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Since 1988, juvenile oyster disease (JOD) has resulted in high seasonal losses of cultured Eastern oysters
(Crassostrea virginica) in the Northeast. Although the cause of JOD remains unknown, most evidence is consis-
tent with either a bacterial or a protistan etiology. For the purpose of discerning between these hypotheses, the
antibacterial antibiotics norfloxacin and sulfadimethoxine-ormetoprim (Romet-B) were tested for the ability to
delay the onset of JOD mortality and/or reduce the JOD mortality of cultured juvenile C. virginica. Hatchery-
produced C. virginica seed were exposed in triplicate groups of 3,000 animals each to either norfloxacin,
sulfadimethoxine-ormetoprim, or filter-sterilized seawater (FSSW) and deployed in floating trays on the Dama-
riscotta River of Maine on 17 July 1997. Each week thereafter, a subset of animals from each group was reex-
posed to the assigned treatment. Repeated immersion in either a sulfadimethoxine-ormetoprim or a norfloxa-
cin solution resulted in a delay in the onset of JOD mortality in treated animals and reduced weekly mortality
rates. Weekly treatments with either norfloxacin or sulfadimethoxine-ormetoprim also resulted in a statisti-
cally significant reduction in cumulative mortality (55 and 67% respectively) compared to animals treated week-
ly with FSSW (81%) or those that had received only a single treatment with either norfloxacin, sulfadimeth-
oxine-ormetoprim, or FSSW (77, 84, and 82%, respectively). Bacteriological analyses revealed a numerically
dominant bacterium in those animals with obvious signs of JOD. Sequence analysis of the 16S rRNA gene from
these bacteria indicates that they are a previously undescribed species of marine a-proteobacteria.
The Eastern oyster, Crassostrea virginica, is the primary spe-
cies of bivalve cultured in the northeastern United States (41).
Growers who use hatchery-produced seed maintain the juve-
niles in floating trays for the first season of maturation.
Epizootics of C. virginica during this “nursery” phase were
unknown prior to the emergence of juvenile oyster disease
(JOD) in the late 1980s. JOD has since become enzootic in
several growout sites in Maine, Massachusetts, and New York,
where annual JOD-attributable losses may exceed 90% of the
total production (9, 12).
JOD affects only cultured Eastern oysters, and although the
impact of this disease may vary from year to year, animals ,25
mm in shell height appear to be especially vulnerable and incur
the highest mortality (9, 12). In areas where JOD is enzootic,
JOD episodes occur late in the summer (July to September),
when water temperatures exceed 20°C and salinities are 27 to
33 ppt (4, 9, 12). Affected oysters first exhibit a reduction in
growth rate, followed by morphological signs such as fragile
and uneven shell margins, cupping of the left valve, and mantle
retraction and abnormalities. In addition, a generalized host
response is often manifested as the deposition of a thick ring of
proteinaceous material (conchiolin) around the periphery of
the mantle (9, 12). Deaths are observed coincident with or
shortly after the onset of such signs, and within a period of a
single week, losses may exceed 50% (4, this study).
Efforts to isolate a putative pathogen have been unsuccess-
ful, and standard histological examinations of diseased animals
have failed to reveal a conspicuous association of any single
protozoan, bacterial, or viral agent (9, 17, 34, 35). Likewise,
there is no evidence that JOD results from the presence of
noxious phytoplankters (28, 30), yet the agent is believed to be
biological because the disease has been successfully transmit-
ted between animals in laboratory-maintained aquaria (30).
On the basis of the accumulated evidence, and because there
seems to be no other plausible origin, it is now generally be-
lieved that JOD is caused by a previously unrecognized pro-
tistan or bacterial pathogen.
Some researchers have observed coccoid bodies of uncertain
origin in the mantle lesions of JOD-affected animals (9, 16, 29,
39). These Feulgen-positive basophilic bodies have been inter-
preted as either evidence of a parasitic life stage (16, 29, 39) or
degenerating oyster hemocytes (9). Additionally, there has
been success in reducing mortalities of experimentally infected
animals with erythromycin (30). This result was interpreted by
the investigators to be consistent with a protistan etiology
because this antibiotic may be effective against some protists.
However, considering that the primary use of erythromycin is
to control bacterial infections, this result is not compelling
evidence that excludes bacteria as the etiological agent.
Bacteria have been observed in mantle lesions of JOD-af-
fected animals (9), and there are striking similarities between
JOD and the brown ring disease of Manila clams caused by the
bacterium Vibrio tapetis (8, 18, 32, 33). To test the hypothesis
that JOD may be caused by a Vibrio sp., Lee et al. (28) con-
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ducted an extensive study in which Vibrio levels in cultured
juvenile oysters and water and sediment samples were moni-
tored from May to September of 1993 at a nursery in New
York that experiences seasonal deaths due to JOD. Concen-
trations of Vibrio spp. in both sediments and oysters were
observed to significantly increase once the water temperature
exceeded 20°C, and deaths of juveniles were observed shortly
thereafter (within 1 to 2 weeks). However, no single Vibrio sp.
was consistently isolated from JOD animals, and attempts to
reproduce JOD signs with a number of Vibrio isolates were
unsuccessful. The potential involvement of bacteria other than
Vibrio spp. in JOD-associated deaths was not investigated.
In this study, we used the antibacterial agents norfloxacin
and sulfadimethoxine-ormetoprim (5:1) (Romet-B; Ziegler
Brothers, Gardners, Pa.) in an effort to help elucidate the
etiology of JOD. These antibiotics are both broad spectrum
and bactericidal via inhibition of DNA unwinding and folic
acid synthesis, respectively (14, 20). Specifically, we were in-
terested in determining if the onset and impact of JOD could
be affected by exposure to antibacterials. In addition, in an
effort to discern the involvement of bacteria other than Vibrio
spp., a nonselective medium was used for bacteriological anal-
yses to maximize the recovery of total viable bacteria from
healthy, JOD-affected, and recovered oysters.
MATERIALS AND METHODS
Media and antibiotics. Bacteria were isolated and maintained on a seawater-
based complex medium (SWT) (7). Strains were stored at 280°C in SWT con-
taining 12.5% glycerol. Hugh-Leifson oxidative-fermentative medium was pre-
pared as previously described (40).
Stock solutions of norfloxacin (Sigma, St. Louis, Mo.) and sulfadimethoxine-
ormetoprim were prepared in 1 N NaOH (Baker, Phillipsburg, N.J.) at 20 mg
ml21. Bath solutions contained each antibiotic at 20 mg of active ingredients
ml21 and NaHCO3 at 1% (wt/vol) in filter-sterilized seawater (FSSW).
Oyster treatments and deployment. Approximately 9,000 juvenile C. virginica
(2.5-mm shell height) were obtained from a local shellfish hatchery. Ten animals
were set aside for subsequent bacteriological analysis. The remaining animals
were divided into three equal groups, and each group was treated in triplicate
(approximately 1,000 animals per treatment) by immersion in either FSSW or a
norfloxacin or sulfadimethoxine-ormetoprim solution for a period of 3 h. The
animals were then rinsed with seawater, and each container of 1,000 animals was
again divided into two equal groups. One group of each of these pairs was
designated the repeat-treatment group and thereafter received weekly treat-
ments of the corresponding antibiotic or FSSW. The other group of each pair was
designated the single-treatment group and was not subsequently exposed to
either antibiotic or FSSW.
Each group of approximately 500 animals was placed into open-ended mesh
bags (33 by 61 cm) constructed of fiberglass window screen (1-mm2 openings) for
a density of approximately 5,000 m22. Each bag was then closed via attachment
to a rectangular frame (36 by 36 cm) constructed of 0.5-in. PVC pipe, placed into
buoyant polyethylene cages (7.6 by 41 by 51 cm), and deployed at a commercial
nursery on the Damariscotta River in Maine (44° 19 000 N, 69° 329 450 W). Water
temperature at this site was recorded every 12 h by an automatic temperature
logger (Ryan RTM 2000; Ryan Instruments, Redmond, Wash.), and salinity
measurements were taken weekly with an optical refractometer.
Weekly sampling and monitoring. At 1-week intervals after the initial date of
deployment, all 18 bags of animals were retrieved from the floating trays. Each
bag of animals in the repeat-treatment group was emptied into a separate
container (nine total) and reexposed via immersion to the assigned treatment for
3 h. During this time, animals in the single-treatment group were left in their
bags and kept immersed in flowing seawater. After removal from the treatment
solutions, the repeat-treatment animals were rinsed in fresh seawater. The total
numbers of live and dead animals in all groups were recorded, and dead animals
(i.e., empty shells and those with decaying meat) were removed. Growth perfor-
mance was monitored by measuring the shell heights, with digital calipers (60.1
mm), of 30 randomly selected animals from each bag. Sampling for bacteriolog-
ical analyses was conducted biweekly. At least three animals were removed from
each bag, sealed in waterproof baggies, and packed in ice. Each week following
the completion of sampling, all bags were redeployed in floating cages at the
nursery site.
Mortality assessment and statistical analyses. Instantaneous mortality (i)
represents the percentage of animals on any given date that had died during the
interval since the previous sampling date. Thus, each week, the number of
animals redeployed at the nursery site equaled the total number of animals alive
at the end of the previous week minus the number of animals that had died (i)
and the number of animals removed for further analyses. Cumulative mortality
(CM) is derived from the instantaneous-mortality rates and is expressed as
CM 5 1 2 eSi (23).
Mortality data were subjected to the arcsine transformation prior to analysis
(44). A standard one-way analysis of variance and Dunnett’s post-hoc test (a 5
0.05) were conducted on the transformed CM data by using the Statmost 3.5
statistical package (Dataxiom Software, Inc., Los Angeles, Calif.). Growth data
were analyzed by using a standard analysis of variance and Dunnett’s post-hoc
test.
Bacteriological analyses of oysters. The 10 seed animals were homogenized
whole (in two groups of five) in 0.5 ml of sterile 70% seawater. The samples were
serially diluted in sterile 70% seawater and spread onto SWT agar plates. On all
other dates, unless otherwise noted, animals from any given tray were processed
together. After rinsing with FSSW (3 3 40 ml in a sterile petri plate), the
adductor muscle of each animal was severed by using a flame-sterilized scalpel
and forceps. Tissues were removed and combined in 0.4 ml of sterile 70%
seawater and homogenized with a sterile pellet pestle. The samples were then
diluted and plated as described above. All plates were incubated for 7 days at
23°C before enumeration of CFUs to estimate total recoverable bacteria. The
culture plates were also inspected visually for the presence of numerically dom-
inant colony morphologies, and representatives of abundant types were trans-
ferred to fresh medium for further characterization.
Phenotypic analyses of bacteria. Determination of Gram reaction, motility (in
a wet mount), catalase activity, oxidase activity, and reaction in oxidative-fer-
mentative medium were performed in accordance with standard methods (40).
The capacity for anaerobic growth was tested by using an anaerobic-bag system
(Marion Scientific, Kansas City, Mo.). Selected isolates were also tested for
growth on Marine Agar 2216 (Difco) and thiocitrate sucrose bile salts medium
(BBL, Cockeysville, Md.).
Twenty-five selected oyster isolates and five control strains (two Escherichia
coli and three Aeromonas salmonicida) were tested for susceptibility to norfloxa-
cin and sulfadimethoxine-ormetoprim in a disk diffusion assay. The oyster iso-
lates were unable to grow on the standard antibiotic testing medium (Mueller-
Hinton agar), so all testing was performed on SWT agar. Bacteria from agar
plates were inoculated into 5 ml of SWT broth and grown to an optical density
at 600 nm of 0.16 (equivalent to a 0.5 McFarland turbidity standard) or adjusted
to this density with diluent if necessary. A sterile cotton swab was moistened with
the standardized bacterial suspension and used to inoculate the surface of a
150-mm-diameter SWT agar plate. A disk impregnated with either norfloxacin
(10 mg) or sulfadimethoxine (23.8 mg)-ormetoprim (1.2 mg) was applied to the
center of either half of the inoculated plate. All plates were incubated at 23°C,
and the resulting zones of inhibition were measured with digital calipers to the
nearest millimeter.
DNA purification, amplification of 16S rRNA genes (rDNAs), and sequence
analysis. Genomic DNA was prepared from bacterial cultures as described by
Meade et al. (31) and diluted to 10 mg ml21 in 10 mM Tris-HCl–1 mM EDTA
(pH 8.0). The primers used for amplification of 16S rDNAs were previously
described (26) and correspond to E. coli positions 8 to 27 (primer 27F) and 1492
to 1510 (primer 1492R). Each 50-ml PCR mixture contained 50 ng of genomic
DNA, 2 mM MgCl2, amplification primers (100 nM each), and 200 mM each
deoxynucleoside triphosphate in 13 thermophilic DNA polymerase buffer (Pro-
mega, Madison, Wis.). After an initial 4-min denaturing step (94°C), one wax Taq
bead (Promega Hot Start; 1.25 U/bead) was added to each reaction tube and the
tubes were held at 94°C for an additional 2 min. The thermocycler (Techne Ltd.,
Duxford Cambridge, United Kingdom) was then set to run 35 cycles under the
following conditions: 40 s of denaturing (94°C), 30 s of annealing (62°C), and 60 s
of elongation (72°C), followed by an additional 7 min of elongation at the end of
the program. The PCR products were purified by using a Centricon-100 mi-
croconcentrator (Amicon Inc., Beverly, Mass.), and the purity and concentration
of the DNA were analyzed by electrophoresis on a 1% agarose gel (36). The
purified products were sequenced at the University of Maine’s DNA sequencing
facility by using the ABI Prism Dye Terminator Cycle Sequencing Ready Reac-
tion Kit with Amplitaq DNA polymerase FS (Applied Biosystems Inc., Foster
City, Calif.). The primers used for sequencing included 27F and 1492R, as well
as 530F, 519R, 907R, and 926F (26, 27).
An unambiguous consensus sequence of 1,390 bp was produced by analysis
with Sequence Navigator software (Applied Biosystems, Inc.) and subjected to
BLAST analysis (2). The three sequences identified by the BLAST program as
producing significant alignments were downloaded and manually aligned with
the C. virginica small pink (CVSP) colony type sequence across 1,294 nucleotides.
Gaps were not included in the calculation of percent nucleotide identity between
aligned sequences.
Nucleotide sequence accession numbers. The nucleotide sequences of the
strain CV919-312 and CV1010-362 rDNAs have been submitted to GenBank and
assigned accession no. AF114484 and AF114485, respectively.
RESULTS
Environmental conditions. Water temperature at the nurs-
ery site had reached 21°C approximately 3 weeks prior to the
deployment date (Fig. 1). In the weeks thereafter, mean tem-
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peratures stayed between 20 and 22°C before the first deaths
due to JOD occurred in late August. The water temperature
was 19°C when deaths began occurring and continued to de-
crease throughout the period during which deaths due to JOD
occurred. Salinities were fairly constant (between 30 and 33
ppt) from July to November (Fig. 1).
Growth and JOD onset. Juvenile C. virginica in all groups
exhibited rapid growth during the first 4 weeks following de-
ployment at the nursery site (Fig. 2). However, between 13 and
20 August, little growth was noticed in the three single-treat-
ment groups and the FSSW repeat-treatment group (Fig. 2). In
addition, animals in these four groups had developed other
characteristic signs of JOD, including fragility of the shell mar-
gins, exaggerated cupping of the left valve, and mantle retrac-
tion. Juveniles receiving weekly treatments of sulfadimethox-
ine-ormetoprim and norfloxacin had also begun to show overt
signs of JOD at this time, but fewer individuals appeared to be
affected, and the signs were less pronounced. Reductions in the
growth rates of animals in the sulfadimethoxine-ormetoprim
and norfloxacin repeat-treatment groups were not observed for
another 1 and 2 weeks, respectively.
Animals exposed weekly to the antibacterials exhibited over-
all better growth. On each sampling date after 27 August, the
mean shell height of animals in the norfloxacin repeat-treat-
ment group was significantly greater (P # 0.05) than that of
animals in the single-treatment groups and the FSSW repeat-
treatment group. Animals in the sulfadimethoxine-ormetoprim
repeat-treatment group achieved greater shell heights than
animals that had received only a single treatment with either
norfloxacin or sulfadimethoxine-ormetoprim. These differ-
ences were statistically significant on four of the six sampling
dates after 10 September.
Effect of antibiotics on mortality due to JOD. Greater than
99% of all deaths were associated with overt signs of JOD.
Deaths were first observed on 27 August, and the highest
instantaneous mortality rates for animals in the single-treat-
ment and FSSW repeat-treatment groups were observed on 3
September (Fig. 3). Repeated exposure to sulfadimethoxine-
ormetoprim resulted in a 1-week delay in maximum instanta-
neous mortality rates, while the norfloxacin repeat-treatment
groups did not exhibit peak mortalities until 24 September, 3
weeks after the highest mortalities occurred in the FSSW re-
peat-treatment group and all of the single-treatment groups
(Fig. 3). Instantaneous mortality rates in the sulfadimethoxine-
ormetoprim and norfloxacin repeat-treatment groups did not
exceed 25%, compared to peak mortality rates of between 35
and 50% in animals in the single-treatment groups and FSSW
repeat-treatment animals (Fig. 3).
CMs in the single-treatment groups were 77, 84, and 82% for
the norfloxacin, sulfadimethoxine-ormetoprim, and FSSW
treatments, respectively (Fig. 4). Similarly, 81% of the animals
in the FSSW repeat-treatment group died from JOD. Week-
ly treatments with either norfloxacin or sulfadimethoxine-
ormetoprim resulted in statistically significant reductions in
CM of 55 and 67%, respectively (Fig. 4; P 5 0.00008).
FIG. 1. Mean weekly water temperature (■) and salinity (F) at the Damar-
iscotta River nursery site from June to November 1997. The deployment date
(D) and onset of deaths (M) are indicated.
FIG. 2. Growth of experimental groups of C. virginica. The mean shell height
of 30 randomly selected animals from each triplicate bag was determined and
then used to derive the mean shell height of each experimental group. Symbols:
‚, single FSSW treatment; E, single sulfadimethoxine-ormetoprim treatment; h,
single norfloxacin treatment; Œ, repeat FSSW treatment; F, repeat sulfadime-
thoxine-ormetoprim treatment; ■, repeat norfloxacin treatment.
FIG. 3. Weekly mortality rates of experimental groups of C. virginica. Rates
were calculated as described in Materials and Methods, and the symbols are as
defined in the legend to Fig. 2. The data represent the mean of three replicate
trays in each group.
2536 BOETTCHER ET AL. APPL. ENVIRON. MICROBIOL.
Bacterial counts and presence of a dominant colony type.
Juvenile oysters obtained from the hatchery contained approx-
imately 9.0 3 104 recoverable CFUs per animal (meat and
shells combined). All subsequent bacteriological analyses were
conducted on aseptically dissected tissues. Throughout the
course of the study, the total number of bacteria recovered
from oyster meat ranged from below 100 CFU mg21 to above
3 3 103 CFU mg21. Still, the lowest counts were obtained in
samples prior to the onset of JOD, while samples that included
animals showing overt signs of JOD yielded counts that were
elevated approximately 10-fold. For example, the mean num-
bers of CFUs recovered from oysters before (13 August) and
after (27 August) the onset of mortality due to JOD were 3.0 3
102 and 1.6 3 103 mg21, respectively. In addition, five appar-
ently healthy animals and five animals with JOD signs were
removed on 10 September and processed individually for bac-
teriological analyses. Samples from animals without overt signs
of JOD yielded 2.0 3 102 CFU mg21, while 1.7 3 103 CFU
mg21 were recovered from affected animals.
Based on visual inspection of colony types, there was a high
diversity of bacteria isolated from the hatchery seed oysters
and oyster meat prior to 27 August. That is, on plates with
between 20 and 200 CFUs, it was unusual for any colony
morphology to represent more than 10% of the total isolates.
However, beginning on 27 August and continuing throughout
the period during which deaths due to JOD occurred, the
presence of a numerically dominant colony type was observed.
These colonies took 4 to 5 days to achieve a diameter of 1 mm
on SWT agar and comprised between 30 and 95% of the total
recoverable CFUs (Fig. 5). They were uniformly round, non-
mucoid, and nonpigmented until after approximately 7 days,
when the colonies exhibited a distinct light pink coloration (the
CVSP colony type). Frozen stocks of 120 isolates recovered
over a 7-week period were stored for further characterization.
On the last sampling date (29 October), many animals ex-
hibited renewed shell growth (a sign of improved health). Bac-
teriological analyses of these animals (n 5 6) revealed an
absence or very low prevalence of CVSP bacteria (,1% of the
total CFUs). In contrast, CVSP bacteria were still isolated at
this time in significant numbers (between 18 and 60% of the
total CFUs) from animals that did not exhibit such signs of
recovery from JOD.
Characterization of the dominant CFU. All 120 CVSP iso-
lates exhibited the following characteristics. They were gram-
negative rods (approximately 0.25 by 1.0 mm), exhibited flagel-
lar motility, were oxidase positive, were weakly catalase
positive, and produced no reaction in oxidative-fermentative
medium. Of 10 isolates tested, none were found to be capable
of anaerobic growth. The 25 isolates tested for susceptibility to
norfloxacin and sulfadimethoxine-ormetoprim exhibited simi-
lar sensitivities to these antibiotics (Table 1). The average zone
of inhibition resulting on CVSP bacterium-inoculated plates
was at least twice the size recorded for each of the resistant
control organisms tested.
Genomic DNA was prepared from two CVSP bacteria
FIG. 4. CM of experimental groups of C. virginica. Calculations are described
in Materials and Methods, and symbols are defined in the legend to Fig. 2. The
data represent the mean of three replicate trays in each group.
FIG. 5. Percentages of total CFUs recovered from weekly samples that ex-
hibited the distinct colony morphology of CVSP bacteria as described in the text.
The data represent the mean of six experimental groups, and the error bars
represent 1 standard deviation.
TABLE 1. Susceptibility of norfloxacin-sensitive and norfloxacin-
resistant E. coli, sulfadimethoxine-ormetoprim-sensitive and
sulfadimethoxine-ormetoprim-resistant A. salmonicida, and CVSP
isolates to norfloxacin and sulfadimethoxine-ormetoprim










E. coli KD65 Drlica and Zhao 1 37 30
E. coli KD66c Drlica and Zhao 1 22 22
A. salmonicida 80204 G. Olivier 1 39 21
A. salmonicida 96276d G. Olivier 1 41 6
A. salmonicida 96362d G. Olivier 1 39 6
CVSP isolates 09/17/97 5 48 6 1.3 19 6 0.9
CVSP isolates 09/24/97 5 49 6 1.6 19 6 1.7
CVSP isolates 10/01/97 5 51 6 1.8 21 6 2.0
CVSP isolates 10/08/97 5 51 6 0.9 20 6 1.9
CVSP isolates 10/29/97 5 51 6 1.2 21 6 2.2
a Zones were measured after 48-h incubation of E. coli and A. salmonicida and
after 72-h incubation of CVSP isolates. Five CVSP isolates collected on each of
five isolation dates were tested. Each disk (impregnated with either norfloxacin
[10 mg] or sulfadimethoxine [23.8 mg]-ormetoprim [1.2 mg]) was 6 mm in diam-
eter, and all zones were measured to the nearest millimeter.
b This study was the source of all of the CVSP isolates tested.
c Norfloxacin-resistant strain.
d Sulfadimethoxine-ormetoprim-resistant strain.
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(strains CV919-312 and CV1010-362) that had been isolated 3
weeks apart. Using PCR, we amplified 16S rDNAs from these
strains; we then purified the products and submitted them for
sequencing. These rDNAs yielded identical unambiguous se-
quences of 1,390 bp. The 16S rDNAs of a-proteobacterium
MBIC3951, Roseovarius tolerans (24), and marine bacterium
isolate SRF3 were identified by the BLAST program as pro-
ducing the most significant alignments with the CVSP se-
quence. The corresponding accession numbers of these se-
quences are AB018689, Y11551, and AJ002565. The sequence
identity percentages of the sequences aligned (excluding gaps)
with the CVSP sequence were calculated to be 96.0, 94.8, and
94.4%, respectively.
DISCUSSION
The transmissibility of JOD among oysters held in artificial
seawater (30) suggests that JOD is caused by a biological
agent. Specifically, a previously unknown bacterial or protistan
pathogen is believed to be involved, although certain environ-
mental factors and/or abiotic agents may also contribute to the
development of JOD in areas where JOD is enzootic. Anti-
bacterial agents were used in the current study for the sole
purpose of gaining insight into the nature of the JOD agent.
Norfloxacin and sulfadimethoxine-ormetoprim were selected
because they possess the following desired properties: (i) a
broad spectrum of activity against bacteria (and each agent
affects essential but unrelated bacterial enzymes); (ii) bacteri-
cidal rather than bacteriostatic activity, making them useful for
short-term immersions; (iii) selective toxicity for bacteria; and
(iv) activity and stability in seawater (1, 10, 14, 20, 42).
The effects of a single immersion and a weekly immersion
regimen were tested because we believed that there could be
three principle processes by which bacteria might be involved
in deaths due to JOD. First, generalized bacterial colonization
of seed oysters in the warm, nutrient-rich environment of a
shellfish hatchery might predispose animals to infection by the
primary JOD agent (bacterial or protistan). Alternatively, seed
oysters could be colonized by a specific bacterium during pro-
duction in a hatchery that later (given the appropriate envi-
ronmental conditions) may contribute to mortality due to
JOD. Lastly, the oysters may become colonized by a primary
bacterial agent and/or secondary opportunists after deploy-
ment at sites where JOD is enzootic.
To date, the occurrence of JOD has not been correlated with
the source of seed oysters (5, 9, 17). Together with our finding
that the timing and patterns of JOD-induced mortality were
similar in animals that either received a single-treatment bath
or were exposed to just FSSW (either on the day of deploy-
ment or weekly), we think it is unlikely that hatchery-acquired
bacteria contribute either directly or indirectly to JOD. In-
stead, the delay and reduction in animal mortality observed
when a repeat antibiotic exposure schedule was used are con-
sistent with the presence of an infective bacterium at the site
where JOD is enzootic.
Animals receiving weekly treatment with either norfloxacin
or sulfadimethoxine-ormetoprim exhibited significantly en-
hanced growth. Although previous experiments have shown
that larger animals are less susceptible to death due to JOD, in
this study, all animals had achieved similar sizes when the first
signs of JOD appeared. Thus, the effect of the antibacterial
agents on mortality does not appear to be a side effect of this
eventual growth advantage. In fact, the antibiotic treatments
more likely resulted in increased growth by delaying the onset
of JOD and the usual accompanying adverse effects on growth
rates. Another consideration is the possible effect of declining
temperatures on the reduction of the mortality rate of animals
receiving repeat therapy. Specifically, both field and laboratory
transmission experiments have shown that temperature is a
factor in the development of JOD (9, 30). However, although
cooler water temperatures may result in a delay in the onset of
external signs of JOD, CM is not ultimately reduced compared
to that of cohorts reared at a warmer site (13). Thus, the results
of our study indicate that the delay and significant reduction of
deaths due to JOD experienced by animals exposed to weekly
3-h immersions in either norfloxacin or sulfadimethoxine-
ormetoprim were a direct result of the bactericidal activities of
these agents.
We discovered that a numerically dominant bacterium (des-
ignated CVSP) was present in JOD-affected oysters. In con-
trast, there were no distinct colony morphology types consis-
tently recovered from healthy oysters (before the onset of
JOD) or from animals showing renewed shell growth. The
demonstrated sensitivity of the CVSP isolates to norfloxacin
and sulfadimethoxine-ormetoprim is consistent with a pro-
posed role for these bacteria in mortality due to JOD. The 16S
rDNA sequences of two representative CVSP isolates were
found to be identical and aligned most closely with the 16S
rDNAs of marine members of the a-proteobacteria. Interest-
ingly, several species of marine a-proteobacteria have just re-
cently been identified as symbionts of a variety of marine plant
and animal species (3, 6, 11, 25, 37) and there is growing
interest in their role as members of coastal (21), Antarctic ice
(22), and hydrothermal-vent (43) communities.
There are several reasons why these a-proteobacteria may
have not been reported in prior investigations of the etiology of
JOD. The best explanation may be that no one suspected the
primary involvement of bacteria other than Vibrio spp. in JOD.
Members of this genus are the most common pathogens of
cultured bivalves (15, 38), and there are strong similarities
between JOD and a similar Vibrio-caused disease of Manila
clams (18, 33). Consequently, investigators have specifically
tried to isolate Vibrio spp. from JOD-affected animals by using
enrichment techniques and selective media (19, 28, 30) that are
unsuitable for the growth of CVSP bacteria. Even when non-
selective media are used, the CVSP type of bacteria may be
missed because they grow slowly at 23°C (the temperature
normally used for incubation during routine recovery of bac-
teria from shellfish). Many marine Vibrio spp. form visible
colonies within a day at 23°C, yet it takes at least 4 days at this
temperature for a CVSP bacterium to achieve a colony diam-
eter of 1 mm on either SWT or Marine Agar 2216. Other
biases may be a result of how animals were treated prior to
dissection. In one series of experiments, a 10% bleach solution
was used to sterilize the surfaces of JOD-affected animals
before dissection and processing for bacteriological analyses
(30). This approach is problematic because evidence suggests
that the JOD agent is primarily associated with external mantle
and periostracum tissues (9). Young oysters (especially those
with uneven valves that result from JOD) are unable to form a
watertight seal, so it is likely that such treatment resulted in an
inaccurate assessment of resident bacteria. Indeed, those in-
vestigators reported that they were unable to recover any bac-
teria from bleach-treated oysters by direct plating.
The results of this study provide evidence that a previously
unidentified species of a-proteobacteria is involved in JOD
mortality. To our knowledge, this study also documents the
first successful cultivation of marine a-proteobacteria from a
defined animal host. CVSP bacteria may be the etiological
agent of JOD or efficient colonizers of affected animals. We
did not observe the presence of CVSP bacteria in animals
before deaths began occurring, which might indicate that these
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bacteria are opportunistic and JOD is caused by another
agent(s). However, this conclusion does not seem consistent
with the generalized tissue emaciation and necrosis observed in
affected animals, which would be expected to support a wide
variety of secondary colonizers. Alternatively, low levels of
CVSP bacteria may have been present in animals before
deaths began occurring but were not detected by direct plating.
We are currently developing more-sensitive detection tech-
niques for these bacteria and are conducting experiments to
test for the ability of a CVSP isolate to induce JOD signs and
death in juvenile C. virginica.
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